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In this literature review, the evidence and theoretical explanation of the 
Gut-Microbiota-Brain axis and its role in neuropsychiatric disorders is presented. There is 
now a paradigm shift in neuroscience toward an increasingly supported understanding of 
neurobiology in terms of not only the CNS, but also the so-called “second brain” residing 
in the enteric nervous system of the gut and its resident microbiota. Accordingly, more 
and more research is looking into the possible role of this second brain in the 
psychopathology of psychiatric disorders, such as major depressive disorder (MDD) and 
neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD) 
and autism spectrum disorder (ASD). This review outlines a burgeoning explanatory 
model, which, if further supported by more rigorous studies, has the potential for the 
development of novel psychiatric treatments via modulation of gut-microbiota dysbiosis 
with pro/pre-biotics, fecal microbiota transplantation (FMT), etc., as well as a 
theoretically promising avenue to disease prevention via intervention into the 
gut-microbiota during the neurodevelopmental windows in which we think ADHD and 
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 The Neurobiology of The Gut-Microbiota-Brain Axis 
It has been noted that the number of microorganisms in the human body 
outnumber the number of human cells tenfold, with these microbes jointly containing 
over 100 times more genes than our own genome (Gill et al. 2006; Handley, Dube, and 
Miller 2006). A great number of these microbes are located on the lining of the gut, 
where they comprise a complex ecosystem which has been called the gut microbiota. 
Research has found that there is a complex interaction between the host and its resident 
gut microbiota, with effects ranging from energy metabolism, immunological 
competence and chronic inflammation, to brain functioning and psychological behavior 
(Robles & Guarner 2013). Indeed, this microbiota has been referred to by some as 
another anatomical organ because of its extensive roles in the bi-directional axis with the 
brain, of which will be the topic of this literature review (Clarke et al. 2014). 
 
Structure of the Gut Microbiota 
As used here, the term “microbiota” refers to all of the microbial organisms 
resident in the gut, including archaea, eukaryotes, and viruses in addition to bacteria. Of 




of the gut microbiota in 124 human subjects found 99% of the genes were bacterial with 
the total number of species found amongst the 124 subjects being between 1,000-1,150 
(Qin et al. 2010; Echkburg 2005). The factors impacting the composition of an 
individual’s gut microbiota include genetic predisposition, nutrition, stress, 
environmental factors, history of infection, use of antibiotics, age, and level of physical 
activity ​(Thursby and Juge 2017)​ .  
The majority of the gut microbiota’s colonization begins at birth, as the inside of 
the uterus is relatively aseptic, the fetus is mostly sterile until inoculation either via the 
mother’s birth canal during vaginal delivery, or if cesarean section is to be performed, 
then through contact with the external environment of the hospital and the mother’s skin. 
This disparity in mode of colonization has been shown to cause disparate microbiota 
compositions, such as greater levels of ​Lactobacillus, Prevotella, ​and​ Bifidobacterium 
following vaginal delivery, and ​Staphylococcus ​and ​Cornyebacterium ​as the predominant 









Evidence of Top-Down Communication: 
Hypothalamic-Pituitary-Adrenal 
Axis (HPA Axis) 
Psychological stress is a 
known regulator of physiologic 
systems throughout the body via 
activation of the 
hypothalamic–pituitary–adrenal axis 
(HPA axis), including alteration of 
the gut microbiota composition. 
This stress-mediated effect on the 
gut microbiome has been 
demonstrated in various special 
models. Following provocation of 
separation anxiety in rhesus 
monkeys by separating them from 
their mothers at an early age, their 




social disruption in a mouse model similarly affected the gut microbiota by a decrease in 
Lactobacillus​ population (Galley et al. 2014). In a human model, the ​Lactobacillus​ fecal 
concentrations were tracked in healthy students with the result of lower levels of this 
commensal bacterium during a period of extreme academic stress relative to lower stress 
periods of the semester (Knowles, Nelson, and Palombo 2008). This effect on the 
microbial communities in the gut is believed to be partially mediated by cortisol secretion 
affecting gut integrity, mucus secretion, and motility (Rubio and Huang 1992). The 
increase in intestinal permeability, leaky gut, causes acute and chronic local immune 
activation as illustrated in figure 1, cascading local and systemic inflammatory and other 
immunological responses.  
 
 
Evidence of Bottom-Up Communication: 
Immuno-modulation  
Immunogenic bacteria in the gut can readily cause chronic low-grade 
inflammation, causing release of pro-inflammatory cytokines and substances that may 
gain access to the central nervous system. One pro-inflammatory substance produced in 
the gut, LPS, may interface with the CNS via recognition by its TLR-4 receptor, which is 




interaction alone has been implicated in the psychopathology of depression comorbid 
with irritable bowel syndrome (Daulatzai 2014).  
 
Vagal Transmission 
The vagus nerve serves as the primary form of afferent neuronal communication 
between the gut and the brain. Studies conducted following vagotomy, severance of the 
vagal nerve, show hindered cytokine induction up the vagus nerve following LPS 
activation of IL-1β, which would normally induce inflammatory-related illness (Bluthé et 
al. 1994). Evidence for how important the vagus nerve is in gut-microbiota-brain 
communication was elucidated in a murine model study looking at two groups of rodents: 
both administered the probiotic, ​Lactobacillus rhamnosus​, and only one group 
vagotomized. The results of this study, with significant anxiety, depressive behavior, and 
corticosterone level reductions in only the non-vagotomized group, showing the vagus 
nerve serves as a pivotal mechanism for gut-microbiota-brain interactions (Bercik et al. 
2011).  
Microbial Metabolites 
Of the many metabolites produced by the gut microbiota, short-chain fatty acids 
(SCFAs) are especially relevant to the gut’s interaction with the central nervous system. 




known to upregulate gene expression of an enzyme, tyrosine hydroxylase, which inhibits 
the synthesis of the neurotransmitters noradrenaline and dopamine, as well as upregulate 
dopamine-β-hydroxylase, an enzyme which converts dopamine to noradrenaline 
(Nankova et al. 2014). The medical implications of this known role of SCFAs is 
especially apparent for the many psychiatric disorders thought to be mediated by 
dopamine and noradrenaline levels, such as attention-deficit/hyperactivity disorder and 
depression. Furthermore, a study on germ-free mice showed long term treatment of 
propionic acid decreased ​in vivo​ concentrations of serotonin, GABA, and dopamine 
(El-Ansary, Ben Bacha, and Kotb 2012).  
Production of Neural Substrates 
In addition to microbial metabolites that indirectly act on the central nervous 
system, microbes can also produce a diverse array of substances which affect the brain 
directly, such as neurotransmitters themselves, as well as their precursors. In addition to 
the role of the gut in synthesis of the majority of the body’s serotonin, the gut also serves 
as the source of tryptophan, which crosses the blood-brain barrier into the CNS where it 
is used for further serotonin synthesis (Mawe and Hoffman 2013). It was found that 
germ-free mice have elevated serum levels of tryptophan and reduced serotonin blood 
concentrations relative to wild-type, normally colonized mice, which suggests microbiota 




tryptophan hydroxylase in the gut compared to mice with a healthy gut microbiota (Yano 
et al. 2015).  
Moreover, gut bacteria locally produce other neurotransmitters, such as 
catecholamine, histamine, and GABA which can be transmitted across the intestinal 
lining through enterochromaffin cells to enter into enteric nerve receptors. A major 
inhibitory neurotransmitter, γ-aminobutyric acid (GABA), which in its dysfunction is 
connected to the neuropathogenesis of anxiety, depression, autism, and schizophrenia, is 
produced by the gut bacteria, ​Lactobacillus brevis​ and ​Bifidobacterium dentium ​(Barrett 
et al. 2012). Additionally, it has been suggested that GABA produced in the gut affects 
the brain by crossing the blood-brain-barrier (BBB) and directly enters the CNS 
(Takanaga et al. 2001). However, the gut microbiota is also believed to affect CNS 
GABA levels indirectly through vagal signaling, considering a study showing 
Lactobacillus rhamnosus ​reducing anxiety and depression-like behaviors and increase 
GABA concentrations in mice hippocampi, but only when the vagus nerve is left intact 
(Bravo et al. 2011; Janik et al. 2016). In regard to the microbiota’s role in dopamine and 
noradrenaline concentrations, it is suggested that gut bacteria produce catecholamine 
from studies showing germ-free mice with strikingly lowers levels of these 
neurotransmitters in the cecum than are present in commensal-colonized mice (Asano et 




Great Transformation of Disease Types: The Role of the Gut Microbiota 
The species ​Homo sapiens​ is, in its essence, a superorganism. This much is clear 
from the extensive symbiotic relationship we hold with our resident gut microbiota. It is 
becoming increasingly evident from the many scientific fields researching the 
multi-faceted gut microbiota that a comprehensive understanding of human health 
requires studying our microbial symbiotes as well. The scientific understanding of human 
health as the product of a complex interplay between host and microbiota represents an 
increasingly-supported paradigm in human physiology. As will be elucidated in this 
paper, this paradigm shift in our understanding shows clear potential towards novel 
pathophysiological models of psychiatric disorders, as well as a capacity toward a next 
generation of novel psychotherapeutics based in a completely unique mechanism of 
action–something needed in the SSRI-dominated field of psychiatry.  
In addition to these potential implications from the field of gut microbiota 
research, epidemiological researchers have suggested evidence of microbiomical 
differences between populations shows a relationship of our microbiota’s vast evolution 
in the transition from pre-industrial, infectious disease-predominate causes of human 
morbidity to today’s, post-industrial, state of human health increasingly marred by 
inflammation-driven diseases, such as depression, obesity, and autoimmune diseases 




With the Industrial Revolution came extensive change in humanity’s cultures, 
diets, behaviors, and it was during this time the field of medicine innovated to the extent 
that the once seemingly-unconquerable existence of microorganisms was finally 
susceptible to man-made vaccines and antibiotics. This period in history marks a distinct 
shift in the types of disease burdening humans. Namely, this shift jumps from the 
prevailing affliction of the past–infectious disease– toward the present state of human 
health increasingly affected by a different array of diseases, including autoimmunity, 
such as in asthma and allergies; metabolic disease, such as diabetes and fatty liver 
disease; psychiatric disorders, such as anxiety, developmental, and mood disorders; 
cardiovascular disease, such as coronary artery disease (Liang et al., 2018).  
The “old friends” hypothesis was first proposed by the researcher, Rook, in 2008 
on the basis of another idea termed the hygiene hypothesis, which suggests early 
childhood exposure to particular microbes primes the immune system in such a way that 
prevents the later development of allergic disease. Rook’s 2008 tangential concept of 
“old friends” hypothesized in pre-modern times we lived in a healthy, symbiotic 
relationship with certain commensal bacterial and parasitic organisms (Rook et al., 2008). 
His conclusion, of course, is that in modern day we do not have an adequate exposure to 
these microorganisms, and as a result, our immune system does not properly develop, 




such as mood disorders and autoimmune diseases. 
The relationship between our gut microbiota and this transformation of disease, 
then, appears to reside in our coevolution, or more specifically, in the adaptation of our 
gut microbiota to our new lifestyles in the absence of a complementary change in our 
own human genes. This lopsided evolution of one partner in our vital symbiotic 
relationship has led to a modern, western variant of the gut microbiota–one in which we, 
their hosts, were not evolutionarily adapted to benefit, as well as we might otherwise with 
a healthy microbiota established through millennia of natural selection. It is in our nature 
now to transform our environment, both outside and inside our bodies, at a rate much 
faster than what our own genes can be driven to adaptation through natural selection, and 
as a result, we will continue to see human health increasingly at odds with a microbial 
environment in which our bodies were not adapted to live. In the next chapter of this 
thesis, I will delve into the state of research describing the neuropsychiatric implications 






The Neuropsychiatry of the Gut Microbiota 
 
Attention-Deficit/Hyperactivity Disorder (ADHD) and the Gut Microbiota 
The currently prevailing psychopathological theory of 
Attention-Deficit/Hyperactivity Disorder (ADHD) is neuropsychiatric in nature, 
conceptualizing the disorder as polygenic variations in the functioning of the monoamine 
neurotransmitter systems and alterations in neural network structures. This 
neuropsychiatric paradigm is slowly being joined by a neuro-entero-immunological 
perspective fed by the quickly expanding field of evidence for the bidirectional interplay 
of the gut-microbiota-brain, which is presently transitioning from preclinical research 
into human studies. A significant deviation from the previous tradition of thought, this 
theory emphasizes the role of environmental factors on the development and function of 
the BGM axis leading to phenotypic implications. The strength of a microbiota-derived 
etiologic model here is especially seen in its possible explanation to the long puzzling 
question of the wide variance in worldwide ADHD prevalence, as diet, gut microbiota 
composition, and other environmental factors vary so much in the world’s great 




opens up significant avenues for not only effective treatment of the disorder, but also 
possible prevention.  
  
A Novel Hypothesis for ADHD Etiology: Autonomic Dysregulation Model 
This explanatory model of ADHD suggests the autonomic dysregulation 
seen in ADHD is caused by an imbalanced, less rich and less diverse gut microbiota early 
in life, as well as perpetuated throughout adulthood (Sandgren and Brummer 2018). This 
theory for the fundamental causes of ADHD relays how early life environmental 
differences lead to variations in microbiota composition responsible for the alterations in 
metabolic and immunologic functioning that causes the various symptoms of ADHD. 
During the early life periods of neurodevelopment, autonomic dysregulations lead to 
altered immunologic functioning, as well as altered metabolism and formation of 
pathophysiologically relevant monoamines such as dopamine, serotonin, and the 
neurotransmitter-derivative, tryptophan.  Figure 2 illustrates many of the wide-ranging 
factors thought to play roles in the development of early childhood gut microbiota, as 
well as indicating that a genetic predisposition toward the disorder combined with the 







Mechanisms of Autonomic Dysregulation: 
Altered peripheral metabolism and formation as mediator of CNS GABA concentrations 
 
Central to this neuro-entero-immunological theory of psychopathology in ADHD 
is the idea of a suboptimal (lowered/imbalanced) microbial inoculation in early life 




neurodevelopment, but also the continued metabolic, and other, activity of gut microbiota 
throughout life. One possible mechanism of pathology in ADHD is reduced levels of the 
inhibitory neurotransmitter GABA, and this is gastroenterologically relevant as GABA is 
a common metabolic product of microbial fermentation (Dhakal, Bajpai, and Baek 2012).  
Magnetic resonance spectroscopy (MRS) research has indicated reduced CNS         
levels of GABA in ADHD children (Edden et al. 2012). It has been shown that the                
GABAergic system is responsive to both short- and long-term stress sensitivity in            
rodents, possibly mediated by the neuroactive steroid hormones, such as          
allopregnanolone (Skilbeck, Johnston, and Hinton 2010). Additionally, a study on healthy           
rodents indicates emotional behavior and expression of GABA receptors in the brain can             
be modulated by the introduction of a probiotic, ​Lactobacillus​, and mediated by the             
vagus nerve (Bravo et al. 2011). In accordance with these findings, it is possible an               
altered GABA metabolism or formation in the CNS may be caused by alterations in the               
periphery. 
 
Altered metabolism and formation in the periphery as mediator of CNS monoamines 
(dopamine, serotonin, norepinephrine) concentrations 
 
In line with predominating theories of ADHD pathology is the theory of 




studies have shown that this insufficiency in DA concentrations may have its roots in the 
periphery (Cortese 2012). A study comparing germ-free (GF) mice to control, wild-type 
gut microbiota possessing mice gives support to the hypothesis of peripheral mediation of 
DA, where GF mice demonstrated elevated turnover of monoamines such as dopamine, 
norepinephrine, and serotonin in the striatum, as well as altered expression of anxiety and 
plasticity-related genes in multiple brain regions (Diaz Heijtz et al. 2011).  
In addition to the pathophysiological role of altered CNS dopamine levels 
in ADHD, serotonin has been implicated in impulsivity and hyperactivity symptoms seen 
in the disorder (Banerjee and Nandagopal 2015). Serotonin is widely established to be a 
central component of bidirectional communication of the gut-microbiota-brain axis 
(O’Mahony et al. 2015). In addition to the role of the gut in synthesis of the majority of 
the body’s serotonin, the gut also serves as the source of tryptophan, which crosses the 
blood-brain barrier into the CNS where it is used for further serotonin synthesis (Mawe 
and Hoffman 2013). Important implications of these findings are suggested in the role of 
CNS serotonin modulation of learning and memory function via effects on dopaminergic, 
cholinergic, and GABAergic neurotransmission (Seyedabadi et al. 2014). This is relevant 
to ADHD pathology and gastrointestinal immunologic functioning, as research has 
suggested serotonin signaling properties become altered following intestinal 
inflammation, resulting in decreased functioning and expression of serotonin-selective 




decreased tryptophan transport in boys in combined type ADHD, possibly implying 
decreased serotonin levels in the brain (Johansson et al. 2011).  
 
Altered Immunological Functioning  
It has been suggested that chronic pro-inflammatory immune 
dysregulation, possibly resulting from genetic predisposition, mediates the pathogenesis 
of ADHD​ ​(Verlaet et al. 2014). Evidence for this hypothesis is found in, among others, 
studies showing a significant prevalence of allergic diseases (asthma, urticarial, atopic 
dermatitis, allergic rhinitis) in individuals diagnosed with Attention-Deficit/Hyperactivity 
Disorder​ ​(Chen et al. 2017). Higher intake of the probiotic fermented food, kimchi, 
omega-3 fatty acids, polyunsaturated fatty acids (PUFAs), and lower intake of fast food, 
were associated with lower odds of having ADHD​ ​(Woo et al. 2014). Furthermore, 
immunologic dysregulation has been implicated in not only in the etiology of ADHD, but 
also in its on-going pathophysiology. As with Autism Spectrum Disorders, it has been 
suggested that sensitivities to certain foods, and their subsequent reactions, may act as 
antigens to induce more severe ADHD symptoms (Pelsser et al. 2011). Interestingly, in 
one study, this food sensitivity-related allergic reaction was shown to be non-allergic or 
cell-mediated​ ​(non-IgE, non-IgG mediated) (Pelsser et al. 2011).  
 





These results seem to suggest potential avenues of therapeutic intervention acting           
on the very immunological dysfunction and neurotransmitter metabolism, which seems to           
be implicated in the etiology of the disorder. Even more exciting for the state of               
neuropsychiatry than additional therapeutic methodologies, is the prospect of         
preventative action via early life gut-microbiota inoculation of anti-inflammatory and          
monoamine-promoting probiotics and prebiotics. For a neurodevelopmental disorder with         
a growing prevalence in western societies, this novel explanatory model addresses an            
increasing societal burden, possibly marking the shift toward a future of child psychiatric             















Autism Spectrum Disorder (ASD) and the Gut Microbiota 
The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders 
defines Autism spectrum disorder (ASD) as a developmental disorder that affects social 
communication and behavior development without a clear etiology. Proposed etiologic 
explanations have spanned many paradigms, including epigenetic effects, congenital 
causes, immune dysregulation, exposure to environmental toxins, and, more recently, 
researchers have proposed a link between microbiota dysfunction and the development of 
ASD ​(Alibek et al., 2019)​. Due to findings on the increased incidence of 
gastroenterological disorders in individuals with ASD, researchers began looking toward 
the gut, and its resident microbiota, for possible clues to the etiology of the disorder 
(Holingue et al. 2018)​.  
 
Gut Microbiota Composition and ASD 
There are a plethora of animal studies documenting alterations to the gut’s 
microbial composition associated with neurobehavioral changes, particularly with anxiety 
and depression related effects, but recently there has been an emergence of these studies 




one of age was found to predict cognitive performance at two years of age, with an 
especially high predictive power toward communicative behaviors ​(Carlson et al. 2018)​. 
A 2020 systematic review on the topic, found a trend of increased ratio of 
Firmicutes/Bacteroidetes​ ​and decreased ​Bacteroides​ in ASD individuals relative to 
neurotypical controls; and, as corroborated by every study reviewed, the researchers 
found a significantly decreased absolute abundance of ​Bifidobacterium ​genus in children 
with ASD compared to non-sibling controls ​(Ho et al. 2020)​. However, this same 
systematic review also found the majority of its reviewed studies had contrasting results 
with regards to most trends in microbial composition in ASD. With this finding, the 
study’s authors conclude the gut microbiota by itself is not a sufficiently predictive 
biomarker for ASD, but instead suggest the integration of multiple omics data (i.e., 
metabolomics, transcriptomics, proteomics, microRNAs, and exosomes) to capture a 
more robust image of the gut microbiota’s composition in ASD.  
 
Epi-/genetics in ASD 
The conventionally popular hypothesis of a strong hereditary cause, as supported 
by early studies of monozygotic and dizygotic twins with concordance rates up to 90% 
(Bailey et al. 1995), may have been overestimations of hereditary effect, as the 




ASD in 193 twin pairs was approximately 50%.  
 
Gestational Health in ASD 
While researchers have long believed the amniotic fluid and placenta to be free of 
microbial life ​(Jiménez et al. 2008)​, recently the ​in utero​ environment has been 
demonstrated to be ​not ​sterile ​(Digiulio et al, 2008)​. Furthermore, the fetus itself is now 
known to host a gut microbiota, as researchers have found the meconium, or the first 
neonatal feces, to contain a range of bacteria, predominant of which were ​Enterococcus 
and ​Staphylococcus​ ​(Jiménez et al. 2008)​.  
In addition to the research looking into the newly appreciated gestational 
microbiota, researchers have investigated the effects of maternal health on the health of 
gestational microbiota and the resulting health of neonates. In one study, obesity and 
diabetes during pregnancy was found to produce characteristic changes in the gut 
microbiota of the neonate, with these alterations being associated with ASD ​(Connolly et 
al. 2016)​. Moreover, this study also found a high-fat diet alone to be enough to alter the 
neonate’s microbiota in the characteristic manner associated with ASD.  
 




Just as researchers began to look into the rise in cesarean section (c-section) rates 
as a potential risk factor in prevalence of ADHD, studies have now been performed 
which implicate this mode of delivery in the etiology of ASD as well ​(Curran et al. 2015)​. 
Compared with vaginal delivery, one study demonstrated an odds ratio of 1.26 for 








Figure 3: Microbial Colonization Variation by Mode of Delivery. In vaginal delivery, 
Lactobacillus ​predominates as the major genus of bacteria to first colonize the infant. In 
cesarean section, however, the skin bacteria ​Staphylococcus​ predominates. The 
introduction of skin microbes may then lead to dysbiosis of the gut, resulting in increased 
risk for immunological disorders such as atopic disease, asthma, celiac disease, and 






Inflammation in ASD 
An increasing amount of research is investigating inflammation as a key player in 
ASD etiology and ongoing pathophysiology. A systematic review analyzed the research 
trends of 437 publications on ASD from 1971 to 2010, finding 95% (416) implicated an 
association between ASD and inflammation ​(Rossignol and Frye 2012)​. Accordingly, the 
gut microbiota has also been implicated in systemic inflammation, via activation of the 
vagus nerve, as well as production of immuno-modulatory short chain fatty acids 
(SCFAs) ​(Richard E. Frye et al. 2017)​. SCFAs, such as propionic acid and butyric acid, 
have shown to modulate the immune system in several manners, including the regulation 
of T-cell and cytokine activation, increasing expression of immune-activating genes, as 
well as the homeostasis of microglial cells during neurodevelopmentally critical periods 
(Richard E. Frye et al. 2017; R. E. Frye et al. 2016; Erny et al. 2015)​. 
 
Microbiota-based Interventions for ASD 
At this time, there exist no definitively effective interventions for ASD, but there have 
been many small studies with preliminary data that suggest efficacy for probiotics and 





Table 1.) Examples of Typical Quality/Size of Pro/Pre-biotic Studies  



















































































Major Depressive Disorder (MDD) and the Gut Microbiota 
 
Major Depression is characterized by a low mood and/or anhedonia, the inability 
to experience pleasure, for more than two consecutive weeks, and is a leading cause of 
morbidity, disability, and mortality (aan het Rot, Mathew, and Charney 2009). Theories 
of the physiological cause of the disorder range widely, from the most popular theory 
among clinicians– that of altered neural functioning, including imbalances in 
neurotransmitter levels (aan het Rot, Mathew, and Charney 2009)– to explanations of 
altered functioning in the HPA axis, the immune system and, finally, the 
gut-microbiota-brain axis (Chaudhury, Liu, and Han 2015; Singhal and Baune 2017)​. 
These four predominating theories on the etiology, or the manner of causation, of 
depression form the basis of the following chapter.  
 
The History of Pathophysiological Theory of Major Depressive Disorder: 
Theories of Altered Neural Functioning 
 
Of the three main hypotheses within the umbrella of neural malfunctioning 
theories of depression, the most popularly known ​monoamine hypothesis​, which 
suggests imbalances in key mood-related neurotransmitters play a role in the 




these neurotransmitters believed to help regulate mood are serotonin and norepinephrine. 
It has been shown that in people with a personal and family history of depression, 
pharmacologically-induced low levels of serotonin, via administration of a tryptophan 
depleted diet of amino acids, does indeed induce episodes of depression. However, this 
theory, in spite of its wide clinical acceptance, is undermined by 
methodologically-comparable studies on patients without personal or familial histories of 
depression, whereby the depletion of their serotonin levels does not cause a resultant drop 
in mood (aan het Rot, Mathew, and Charney 2009).  
  
The next etiological hypothesis of depression within the explanatory umbrella of 
neural models is the ​neuroplasticity hypothesis​, which suggests symptoms of depression 
arise from an impaired neuroplasticity induced by CNS-based risk factors such as 
neurotransmitter imbalance and decreased brain derived neurotrophic factor (BDNF) 
levels (B. Liu et al. 2017; Williams 2016)​.​ The BDNF protein is a member of the 
neurotrophin family of growth factors, which is essential for the growth and survival of 
neurons in the brain. The rationale for this hypothesis can be partly seen in the delayed 
onset of symptom reduction from standard antidepressant (AD) treatment, whereby 
increased synaptic serotonin, or norepinephrine and dopamine, concentration does not 
itself account for the antidepressant efficacy of the treatments (B. Liu et al. 2017). On a 




clinical onset of symptom reductions. This multi-week delay in treatment occurs in spite 
of increased synaptic concentrations of monoamines starting from the very first 
administration. It then follows that there must be some other neurological effect from 
these monoamine-increasing antidepressants which can mediate the amelioratory results, 
especially an effect that is time-delayed as to account for the 4-6 week delay of symptom 
reduction onset. This is where the neuroplasticity hypothesis comes in. In this 
explanatory framework, standard antidepressant therapies such as selective serotonin 
reuptake inhibitors (SSRIs) exert an unintentional yet clinically-mediating effect on the 
brain’s neuroplasticity that account for the ultimately effective, yet delayed, characteristic 
of the treatment.  
 
The neural circuit hypothesis suggests depression is the result of 
miscommunications across specific neural circuits of the brain. This multi-circuit 
miscommunication is caused by irregular interaction of neural structures thought to be 
fundamental to mood states, such as dopaminergic (dopamine-releasing) neurons in the 
ventral tegmental area (VTA), a major neural structure of dopamine production, and 
5-HT (serotonin-releasing) neurons in the dorsal raphe nucleus, the serotonin counterpart 
of the VTA. Studies on deep brain stimulation, the electromagnetic manipulation of the 




are the result of normalization of the communication abnormalities in these neural 
circuits (Chaudhury, Liu, and Han 2015; Williams 2016).  
 
Theories of Altered HPA Axis Functioning 
 
One hypothesis in the biological development of depression implicates an 
exaggerated case of the normal physiological response to stress across the HPA axis– the 
intersection of the central nervous system and the endocrine system. This extreme 
sensitivity in the HPA axis results in increased release of corticotropin-releasing factor 
(CRF) and vasopressin (AVP) by the hypothalamus. As a result of CRF and AVP release, 
the anterior pituitary gland secretes adrenocorticotropic hormone (ACTH), which 
stimulates the release of adrenocortical hormones, including glucocorticoid (GC), which 
causes a negative feedback circuit, as GC inhibits the secretion of CRF and AVP by the 
hypothalamus (Barden 2004; Kunugi et al. 2010). The theory of depression by altered 
HPA functioning suggests excessive circulation of GC, which causes desensitization of 
the glucocorticoid receptor (GR), resulting in a dysfunction of the healthy negative 
feedback circuit to keep the HPA stress response in check. Indeed, this dysfunctional 
negative feedback circuit is seen in over half of depressed patients, leading to a chronic 
increase in GC and ACTH, and even hyperpotassemia, elevated levels of potassium (K​+​) 




that HPA axis dysfunction reduces BDNF expression (Kunugi et al. 2010) decreases Glu 
receptor expression, disturbs neuroplasticity and neural circuits (Chaudhury, Liu, and 
Han 2015; Singhal and Baune 2017), and even inhibits 5-HT synthesis (Maes et al. 2011)​. 
These various disturbances in normal physical functions result in the psychological effect 
of depression because of their central role in the regulation of mood states and stress 
responses.  
 
Theories of Altered Immunological Functioning 
 
The cytokine hypothesis–as shown in figure 3– theorizes depression is the result 
of an excessive inflammatory response, resulting from increases in pro-inflammatory 
cytokines such as interleukin-6 (IL-6) and TNF-α and decreases in anti-inflammatory 
cytokines such as IL-10 and TGF- β. Cytokines are chemicals secreted by cells of the 
immune system, which have certain effects on other cells, such as initiating inflammatory 
responses. The overall inflammatory response leads to inhibited negative feedback of the 
HPA axis, causing the bundle of physiological reactions described above, including 
reduction of serotonin synthesis, disturbed glutamatergic systems, increased blood-brain 
barrier permeability, and, therein hypothesized, depression (Maes et al. 2011; Schiepers, 
Wichers, and Maes 2005; O’Brien, Scott, and Dinan 2004; Wichers and Maes 2002; 





Figure 3: Stress and the Gut Microbiota. Stress is a ubiquitous phenomenon in the 
etiology of major depressive disorder. Psychological stress acts in a top-down manner to 
activate the HPA axis by directly inducing release of corticotropin-releasing hormone 
(CRH) and vasopressin (AVP) along with more indirect pathways starting from the gut. 
Gut pathogens, for example, can cause altered gut barrier functioning, or “leakiness”, 
which results in transmission of pro-inflammatory molecules, such as lipopolysaccharide, 
into the bloodstream. This immune activation can act on the hypothalamus with increased 
interleukin-1 (IL-1) and interleukin-6 (IL-6) levels, as well as directly stimulation of the 
adrenal cortex by prostaglandin E​2​ (PGE​2​). 
Psychobiotics can act against this proinflammatory state by elevation of 
anti-inflammatory cytokines interleukin-10 (IL-10) and suppression of pro-inflammatory 





Altered Gut-Microbiota-Brain Functioning: A More Fundamental Explanation  
 
As can be seen in a broad view of the above etiological theories of major 
depressive disorder, this psychopathology is not merely a mental disorder confined to the 
brain, but it is a systemically-defined biological disease characterized by physiological 
systems incorporating immunological, hormonal, and epigenetic causes– among many 
others. Intuitively, scientists conceive of disorders with seemingly far-flung etiological 
foundations as containing a single yet-to-be-determined foundation and elegant 
etiological explanation. Applying this intuition to the etiologically multi-system major 
depressive disorder, the scientific inclination to choose a theory which elegantly connects 
all the mechanistic dots has brought many researchers to view the gut-microbiota-brain 
axis as the intersection and major driving force behind these seemingly disjointed events, 
which culminate in the presentation of depression. Indeed, all of the above described 
pathological mechanisms of depression interplay with each other, and the biological 
theater of this interaction seems to be predominantly located within the various pathways 
of the gut-microbiota-brain axis, begging a proper psychopathological model of 
depression be located on this axis as well.  
 




Phenotypic Composition of Microbiota in Depressed versus Health Subjects 
There has been a marked proliferation of studies investigating the microbial 
differences in the guts of depressed subjects–both in rodent models and human patients. 
In some of the research on human subjects, it was found that depression was associated 
with reductions in both microbiota diversity and richness (Jiang et al. 2015; Kelly et al. 
2016). While phenotypic differences in microbiota composition between control and 
depressed models are still in debate (Lin et al. 2017) and cannot be precisely drawn, a 
few broad (phylum and genus level) distinctions have been identified. In phylum level 
differences, depressed subjects have shown to contain increased richness of 
Proteobacteria and Bacteroidetes and decreased richness of Firmicutes; on the order of 
family, depression is associated with an increased abundance of ​Prevotellaceae​;​ ​on the 
genus level, there is an increased abundance of ​Prevotella​ and decreased abundance of 
Faecalibacterium, Ruminococcus​, and notably, ​Lactobacillus ​and ​Bifidobacterium 
(Jiang et al. 2015; Y. Liu et al. 2016)​. 
Depressive Symptoms Can Be Transmitted Following Fecal Microbiota Transplantation 
Additional support for the tenability of this model as a pathophysiological 
paradigm of depression’s biological underpinnings, as well as the groundings for 




psychological states following transplantation of fecal microbiota from diseased subjects. 
It has been found that transplanting fecal microbiota from depressed human patients to 
germ-free mice results in the presentation of increased depressive symptoms in the 
recipient mice (Zheng et al. 2016). A similar study illuminated the specific depressive 
symptomatic changes in antibiotic cocktail-treated and microbiota-depleted rodents who 
received transplants of fecal microbiota from depressed human patients. This study’s 
results found transfer of depressive symptoms similar to their human microbiota 
providers, such as increased anxiety, anhedonia and tryptophan metabolism disturbances 
(Kelly et al. 2016). The transfer of psychological states and physiological symptoms of 
depression through transference of microbiota is further and strong evidence of the 
regulation of mental states by the gut microbiota. Additionally, this transference 
phenomenon may exist in the acquisition of microbiota from parents via longitudinal and 
horizontal gene transfer, further explaining the hereditary nature of psychiatric illness 
(Yatsunenko et al. 2012). 
Dysbiosis of the Gut Microbiota and Susceptibility to Depression 
Perturbations of the gut microbiota composition are becoming all the more 
common in 21​st​ century western societies. Proliferating antibiotic use, increases in levels 
of chronic stress, and increasingly processed, poor diets, all serve to perturb human gut 




Sonnenburg et al. 2016; Sandhu et al. 2017). Despite the huge advances in human health 
from the threat of infection, antibiotics have indeed served to damage beneficial 
microbes, thereby perturbing the gut microbiota and the connected biological systems 
along the gut-microbiota-brain axis, resulting in increases in incidence of mental 
diseases, as well as somatic illness (Hu et al. 2015; Fröhlich et al. 2016; Wang et al. 
2015). It has been shown that infants treated with antibiotics within the first year of life 
are more likely to suffer from behavioral problems and depression (Slykerman et al. 
2017). Furthermore, the link between chronic stress and depression has been shown to 
not only be mediated by the brain’s stress response system, but also by dysfunctions in 
the gut-microbiota-brain axis (Holdeman, Good, and Moore 1976). It was shown that 
chronic restraint stress disturbs the gut microbiota, leading to bottom-up effects such as 
decreased hippocampus 5-HT content, decreased mRNA expression of BDNF, increased 
stress hormones plasma levels, declines in circulatory IL-10 levels, resulting in 
depression (Liang et al. 2015). Not surprising to dietotherapy theory, diet has been 
implicated in the disruption of healthy gut-microbiota in the context of depression with 
poor diet and its subsequent microbiota perturbation leading to an increased incidence in 
depression (Yatsunenko et al. 2012; Frei et al. 2012). The Western diet, which includes 
highly refined foods, excessive levels of saturated fats, sugar, and food additives, has 




(Slyepchenko et al. 2017).  
 
Traditional Antidepressants and Their Mechanistic Connection to the GMB Axis 
 
There has been a growing research interest into probing the wide range of 
antidepressant therapies for antimicrobial effects on the gut microbiota, leading to the 
emerging hypothesis of antidepressant efficacy being at least partly mediated by the 
gut-microbiota-brain axis (Macedo et al. 2017; Yuan et al. 2015). This growing research 
interest is understandable considering the first antidepressant drug, isoniazid, was 
originally an antimicrobial agent used in ​Mycobacterium tuberculosis ​infections (Macedo 
et al. 2017). Indeed, looking across the many later developed antidepressants, antibiotic 
properties abound: first-generation tricyclic antidepressants (TCAs) inhibit many 
bacteria, including ​E. coli​, ​ Yersinia​, and ​Plasmodium​; selective serotonin reuptake 
inhibitors (SSRIs), the currently most popularly prescribed antidepressant inhibits 
Gram-positive bacteria; the newly developed antidepressant ketamine inhibits 
Staphylococcus​, ​Enterococcus​, and ​Candida albicans​. Even more, it has been shown that 
the common antibiotics, such as minocycline and ceftriaxone sodium, possess 
antidepressant effects (Macedo et al. 2017). Together, the commonality in effects these 






Modulation of the Gut Microbiota as a Treatment of Depression 
 
In addition to research showing compelling evidence for dysbiosis of gut 
microbiota leading to the development of disease, there is also increasing evidence for 
modulation and restoration of the microbiota bringing improvement to these diseases. 
There are four primary methods that have been shown to effectively recover healthy 
microbiota composition, which are prebiotics, probiotics, healthy diet (defined below), 
and fecal microbiota transplantation (FMT) (Sandhu et al. 2017; X. Liu, Cao, and Zhang 
2015).  
 
Probiotics and prebiotics, which are the live microorganisms which confer health 
benefits to a host and the substrates needed by these health-conferring, commensal 
microorganisms, respectively (Gibson et al. 2017). Due to the effects of these probiotics 
along the entirety of the gut-microbiota-brain axis and their ability to affect psychological 
well being, they are sometimes termed psychobiotics (Dinan, Stanton, and Cryan 2013). 




probiotics capable of alleviating depression at levels comparable to traditional 
antidepressant therapies (Akkasheh et al. 2016). Moreover, the antidepressant effect seen 
in administration of probiotics has been shown in animal models to be mediated 
specifically the gut-microbiota-brain axis (Bharwani et al. 2017; Liang et al. 2015). These 
probiotics shown to possess psychological benefit in these studies include 
Bifidobacterium bifidum ​, ​Lactobacillus casei​, and ​Lactobacillus helveticus ​(Akkasheh et 
al. 2016; Liang et al. 2015). On top of direct modulation of the gut microbiota via 
supplementation of the health-conferring bacteria which may be in insufficient richness, 
modulation of the gut-microbiota-brain axis via supplementation of the raw substrates 
used generally across commensal bacteria, thus increasing richness from a 
microbial-nutritional level (X. Liu, Cao, and Zhang 2015). The most popular of these 
prebiotics being fibers, fructose-oligosaccharide and galacto-oligosaccharide, and 
omega-3 fatty acids (Gibson et al. 2017).  
Similar to modulation of specific key microbial substrates, as in prebiotic 
supplementation, changes in diet can confer comparable effects on gut microbiota 
functionality; specifically, the changes to gut microbiota which result in increased MGB 
axis functioning are thought to be increases in diversity, stability and richness of the 
commensal microbiota (Gibson et al. 2017). Diets can achieve these prebiotic-like 
substrate-mediated effects by containing plentiful unsaturated fats, plentiful fiber, and 




The fourth main method for modulating the gut-microbiota is fecal microbiota 
transplantation from a healthy donor to the gut of a diseased gut, seeking to restore a 
healthy microbiota composition. This procedure has been shown to be effective in the 
treatment of ​Clostridium difficile ​infection, ulcerative colitis, and inflammatory bowel 
disease (Evrensel and Ceylan 2016).  
Taken together, the current research on pro/pre-biotics, healthy diet, and FMT 
suggest these procedures, via their amelioratory effects on the functioning of the 
gut-microbiota-brain axis, may be promising future treatments for major depressive 











Limitations and Future Research Directions 
It is clear, however, by the overwhelming abundance of non-human studies in this 
field of research, that additional studies are required with human subjects so we can 
further illuminate the mechanisms and roles our human gut microbiota serve in the full 
range of neuropsychiatric, metabolic, and other diseases in which the animal model 
studies suggest might be implicated. Another limitation of this field of research is in the 
scarcity of replicated findings. However, it has been noted that the field’s lack of 
replicated findings may not suggest false results, but instead speaks to methodological 
differences in sample collection and data analysis. There are many different techniques 
used to collect samples for microbiota analysis, ranging from a stool sample up to the 
much more invasive submucosal biopsy. The vast majority of published studies on the 
diversity of the gut microbiota utilize stool samples for microbial analysis in place of 
submucosal biopsies (Fraher et al., 2012). This over reliance on stool sampling may be a 
major limitation on the field’s findings, as it has been widely shown that the mucosal 




microbiota profiles between the two sampling methods is relevant to the state of the 
research, as we know stool samples tend to possess an abundance of luminal species 
while lacking entire mucosal populations, which facilitate the chief interactions with the 
immune system (Shi et al., 2017).  
 
A Paradigm Shift in Neuropsychiatric Theory  
The results presented here show a growing interest in the scientific community to 
see neuropsychiatric health in more holistic, multi-system terms, increasingly 
appreciating the “second brain” of the enteric nervous system and its essential resident 
gut microbiota. These results seem to suggest potential avenues of therapeutic 
intervention acting on the immunological dysfunction, microbial metabolite production, 
and neurotransmitter metabolism which are all crucially linked with the physiology of the 
central nervous system. Beyond research investigating the gut microbiota for possible 
treatment modalities, there is much potential for prophylactic measures and novel 
methods of risk screening of different psychiatric disorders based on microbiomic profile.  
 
Public Health Implications  




among populations and individuals is inevitable. These differences can be seen in 
dramatic microbial differences in a study investigating gut microbiota of children living 
in Burkina Faso, who had a ​Firmicutes​/​Bacteroidetes​ ratio of 0.47, while children in Italy 
had a F/B ratio of 2.8 (Filippo et al. 2017). Additionally, even more than the variation 
you would expect between the stark living differences between children in Italy versus 
Sub-Saharan Africa, there is good data to suggest there are differences among ethnic 
groups living in the United States as well. In a 2018 study comparing the gut microbiota 
across 1,673 healthy individuals in the United States, researchers found significant 
differences in taxonomic composition between 4 ethnicities (Brooks et al. 2018). These 
researchers found there are at least 12 microbial taxa which reproducibly vary in 
abundance between ethnicities.  
It is clear from studies such as these, not only is there great taxonomic variation 
among individuals and groups, but these differences correlate tightly with social 
determinants of health, which disproportionately affect members of minority and lower 
socioeconomic status (SES) groups. As such, the gut microbiota may have potential to 
mediate public health disparities, giving further exigency to an already important 
scientific initiative. For this reason and the others described above, it is imperative for the 
fields of microbiomics and neuroscience to continue investigating the roles played by the 
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